Pancreatic Cancer Action Network Receives $500,000 Gift to Expand Patient Services, Helping Patients Navigate the Right Track: Finding the Right Team, the Right Tests and the Right Treatment
Jul 7, 2026 - By Julie Vasquez The Gift is Part of PanCAN’s $250 Million All Together We Can Campaign to Accelerate Breakthrough Research, Expand Patient Support, and Champion a Thriving Community…
Read the full articleYou might also wanna read
Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer
Conditions : Pancreatic Ductal Adenocarcinoma (PDAC) Sponsors : Beijing Daxiang Biotech Co., Ltd; Ruijin Hospital; Beijing Friendship Hospit
New AI Tool Boosts Pancreatic Cancer Detection – Asian Scientist Magazine
In a new study published in Nature Communications, a multidisciplinary team from National Taiwan University Hospital and Academia Sinica dev
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
Conditions : Pancreatic Cancer Interventions : Drug: SBRT + Ipilimumab N01 + Sintilimab + AG Chemotherapy Sponsors : Shandong Cancer Hospita
Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment
Researchers in Spain have developed a therapy protocol that could revolutionize the treatment of pancreatic cancer.
nypost.com·5mo agoA Phase-II Clinical Trial of Radiotherapy to the Coeliac Plexus to Help Pain in Advanced Pancreatic Cancer
Conditions : Pancreatic Cancer Interventions : Radiation: IMRT Sponsors : Royal Marsden NHS Foundation Trust Not yet recruiting
A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients
Conditions : Pancreatic Ductal Adenocarcinoma (PDAC) Interventions : Drug: Inavolisib Sponsors : Fudan University Not yet recruiting
Comments
Sign in to join the conversation.
No comments yet. Be the first.